AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Faruqi & Faruqi investigates potential claims against Semler Scientific.
ByAinvest
Wednesday, Oct 15, 2025 10:49 am ET1min read
Faruqi & Faruqi LLP is investigating potential claims against Semler Scientific, Inc. for securities violations. Investors who purchased or acquired Semler Scientific securities between March 10, 2021, and April 15, 2025, are encouraged to contact James (Josh) Wilson directly at 877-247-4292 or 212-983-9330. The investigation focuses on allegations of securities fraud and misrepresentations by the Company.
Faruqi & Faruqi, LLP, a leading national securities law firm, has announced an investigation into potential claims against Semler Scientific, Inc. (NASDAQ: SMLR) for securities violations. The investigation focuses on allegations of securities fraud and misrepresentations by the Company.
The complaint alleges that Semler Scientific failed to disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act, while discussing possible violations of the False Claims Act in hypothetical terms. This omission led to materially false and misleading statements about the Company's business, operations, and prospects. The investigation also includes allegations that Semler Scientific did not disclose the risk of a civil False Claims Act lawsuit, which could result in significant damages.
The class action lawsuit has been filed against Semler Scientific, and the deadline to seek the role of lead plaintiff is October 28, 2025. Investors are encouraged to register their information through the
. The lead plaintiff will oversee the litigation on behalf of the putative class, and any member of the class may move the court to serve as the lead plaintiff through counsel of their choice or choose to remain an absent class member.Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm encourages anyone with information regarding Semler Scientific's conduct to contact them, including whistleblowers, former employees, shareholders, and others.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet